
Sign up to save your podcasts
Or
This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare
(Episode trigger warning: Descriptions of severe medical trauma.)
In this powerful episode, Karen shares:
- Why thousands of cancer patients are being poisoned because DPYD testing isn’t standard in the U.S.—unlike Europe.
- How underreporting of adverse events masks the true death toll from excessive toxicity. Many fatalities are not accurately noted because patients aren’t being tested.
- The shocking financial cost of ignoring this test—half a million dollars wasted on one preventable death.
- A recent victory: The FDA updated safety labels for fluoropyrimidines, but most doctors still don’t know DPYD testing exists.
- How patients are fighting back! Including one woman who demanded the test, discovered she was DPD-deficient, and saved her own life.
If you or a loved one are facing chemotherapy, this episode could be the difference between life and death. Learn the critical questions to ask your oncologist—before starting treatment.🔗
Resources & Advocacy:
DPYD Foundation: https://www.dpyd.org #TestBeforeChemoColorectal
Cancer Alliance: https://colorectalcancer.org/sites/default/files/media/documents/5FU_guide.pdf
Karan Merritt, co-founder Advocates for Universal DPD/DPYD Testing www.test4dpd.org
Genetics For Healthcare:
LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/
#PrecisionMedicine #CancerCare #PatientAdvocacy
This is GENETICS FOR HEALTHCARE—a podcast dedicated to helping patients and caregivers advocate for precision medicine in treatment, survivorship, disease screening, and prevention. #geneticsforhealthcare
(Episode trigger warning: Descriptions of severe medical trauma.)
In this powerful episode, Karen shares:
- Why thousands of cancer patients are being poisoned because DPYD testing isn’t standard in the U.S.—unlike Europe.
- How underreporting of adverse events masks the true death toll from excessive toxicity. Many fatalities are not accurately noted because patients aren’t being tested.
- The shocking financial cost of ignoring this test—half a million dollars wasted on one preventable death.
- A recent victory: The FDA updated safety labels for fluoropyrimidines, but most doctors still don’t know DPYD testing exists.
- How patients are fighting back! Including one woman who demanded the test, discovered she was DPD-deficient, and saved her own life.
If you or a loved one are facing chemotherapy, this episode could be the difference between life and death. Learn the critical questions to ask your oncologist—before starting treatment.🔗
Resources & Advocacy:
DPYD Foundation: https://www.dpyd.org #TestBeforeChemoColorectal
Cancer Alliance: https://colorectalcancer.org/sites/default/files/media/documents/5FU_guide.pdf
Karan Merritt, co-founder Advocates for Universal DPD/DPYD Testing www.test4dpd.org
Genetics For Healthcare:
LinkedIn: https://www.linkedin.com/company/genetics-for-healthcare-podcast/
#PrecisionMedicine #CancerCare #PatientAdvocacy